tiprankstipranks

Jonathan Javitt Insider Profile

11 Followers
Jonathan Javitt, Director at NextGen Healthcare, holds 8.07K shares in NextGen Healthcare (Ticker: NXGN), holds 14.77M shares in NRX Pharmaceuticals (Ticker: NRXP), holds 0.00 shares in Brainstorm Cell Therapeutics (Ticker: BCLI). Most recently, Jonathan Javitt ― shares of NextGen Healthcare on ― for an estimated value of ―.
tipranks
Jonathan Javitt

Jonathan Javitt
NextGen Healthcare (NXGN)
Director

Ranked #22,061 out of 98,743 Corporate Insiders

Profitable Transactions

50%
2 out of 4 Profitable Transactions

Average Return

+18.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$45M
100.00%
0.00%
A breakdown of Jonathan Javitt's holdings

Insider Roles

NRX Pharmaceuticals
(NRXP)
Chief Scientist, Director, Ten Percent Owner
Brainstorm Cell Therapeutics
(BCLI)
Director
Roles that Jonathan Javitt holds in companies

Most Profitable Insider Trade

Stock:
NRX Pharmaceuticals
(NRXP)
Rating:Informative Sell
Date:Dec 09, 2022 - Dec 09, 2023
Return:+78.80%
The most profitable trade made by Jonathan Javitt

Jonathan Javitt's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
NXGN
NextGen Healthcare
$193.29K
NRX Pharmaceuticals
Aug 24, 2023
Chief Scientist, Director, Ten Percent Owner
Informative Buy
33.00K
$45.19M
Brainstorm Cell Therapeutics
Director
$0.00
List of latest transactions for each holding click on a transaction to see Jonathan Javitt's performance on stock

Jonathan Javitt insider profile FAQ

What is the percentage of profitable transactions made by Jonathan Javitt?
The percentage of profitable transactions made by Jonathan Javitt is 50%.
    What is the average return per transaction made by Jonathan Javitt?
    The average return per transaction made by Jonathan Javitt is 18.40%.
      What stocks does Jonathan Javitt hold?
      Jonathan Javitt holds: NXGN, NRXP, BCLI stocks.
        What was Jonathan Javitt’s latest transaction?
        Jonathan Javitt latest transaction was an Uninformative Buy of ―.
          What was Jonathan Javitt's most profitable transaction?
          Jonathan Javitt’s most profitable transaction was an Informative Sell of NRXP stock on December 9, 2022. The return on the trade was 78.80%.
            What is Jonathan Javitt's role in NextGen Healthcare?
            Jonathan Javitt's role in NextGen Healthcare is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.